Quick Answer
UroGen Pharma Ltd. reported Total Assets of $200.46 million for fiscal year 2025.
UroGen Pharma Ltd. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $200.46M | -29.8% |
| 2024 | $285.71M | +60.2% |
| 2023 | $178.31M | +31.5% |
| 2022 | $135.62M | +13.3% |
| 2021 | $119.75M | -1.9% |
| 2020 | $122.00M | -39.7% |
| 2019 | $202.39M | +95.4% |
| 2018 | $103.56M | +37.1% |
| 2017 | $75.55M | +227.7% |
| 2016 | $23.06M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $185.05M | -38.7% | -11.3% |
| June 30, 2025 | $208.72M | -25.9% | -15.7% |
| March 31, 2025 | $247.62M | +23.5% | -13.3% |
| December 31, 2024 | $285.71M | +60.2% | -5.4% |
| September 30, 2024 | $301.94M | +55.9% | +7.1% |
| June 30, 2024 | $281.85M | +195.6% | +40.5% |
| March 31, 2024 | $200.57M | +77.6% | +12.5% |
| December 31, 2023 | $178.31M | +31.5% | -7.9% |
- UroGen Pharma Ltd. showed a decrease of -29.8% in Total Assets compared to the prior fiscal year.
- Over the 2016–2025 period, UroGen Pharma Ltd.’s total assets has grown by 769.4% (from $23.06 million to $200.46 million).
- The most recent figure is from UroGen Pharma Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: